In GBM, increased levels of miR-296-5p enhanced the invasive properties of cells through the downregulation of caspase-8 and nerve growth factor receptor (NGFR), which were identified as miR-296-5p targets through bioinformatic analysis [69]. This evidence concerns the gene NGFR and glioblastoma.